Clinical investigation of human plasma-derived von Willebrand factor products

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCPMP/BPWG/220/02
Published16/11/2005
Effective from01/06/2006
KeywordsVon Willebrand factor, von Willebrand disease
DescriptionThis document summarises the clinical trials required for authorisation of new and modified human plasma derived von Willebrand factor products.


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more